Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Paracrine signaling by secreted cytokines and growth factors is a method of cellular communication in which signaling molecules (cytokines and growth factors) are locally released from one cell and act on neighboring target cells by binding to specific cell-surface receptors, thereby initiating intracellular signaling cascades and changes in gene expression or cellular behavior. Paracrine communication is essential for coordinating processes such as development, immune responses, tissue repair, cell proliferation, and differentiation. Dysregulation of these pathways can contribute to diseases including cancer, chronic inflammation, and various immune-mediated or fibrotic diseases. Rather than a single protein or receptor, paracrine signaling describes a diverse system mediated by a large family of cytokines, growth factors, and their respective receptors such as EGF, FGF, VEGF, PDGF, TGF-beta, interleukins, interferons, and many others.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Paracrine signaling by secreted cytokines and growth factors.